FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA:

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
280
FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) Makes Play for End Zone Fans

- Sports industry continues healthy growth with four percent CAGR
- Sports fans are the wealthiest Americans
- Sports app gives fans an avenue to cheer and vent

The sports industry in America is thriving. With some 60 percent of Americans identifying as sports fans, the revenues from games, accessories, TV rights and hot dogs must be in the hundreds of billions of dollars. Sports fans, it seems, have money to spend, an observation borne out by Gallup, which found that a higher proportion of wealthier Americans are sports fans than their less well-heeled neighbors. FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) is out to score with these big spenders. The company is launching an aggressive digital marketing campaign to launch its Android Sports App.

Even though the sports industry in America continues to grow at a CAGR of four percent, up from $60.5 billion in 2014 and expected to reach $73.5 billion by 2019, according to Forbes, the proportion of American “sports fans” remains steady at around 60 percent (http://nnw.fm/WY31y). Football tops the list of sports, with 37 percent of respondents choosing it as their favorite. Rounding out the selections, 13 percent chose basketball, 10 percent picked baseball, five percent chose auto racing, four percent went for ice and figure skating and three percent picked ice hockey. Other games, including golf, tennis, soccer, boxing, gymnastics, rodeo, motocross and wrestling, mustered two percent or less.

Not surprisingly, men (66 percent) are much more likely to be sports fans than women (51 percent), and significantly more upper-income Americans (68 percent) regard themselves as sports fans than the 55 percent of middle-income and 54 percent of lower income Americans who do the same (http://nnw.fm/TL3Mb). Upper-income Americans have consistently been much more likely than their less wealthy brethren to identify themselves as sports fans. Indeed, taking into account both income and gender, it turns out that 76 percent of upper-income men are sports fans. These are the guys driving industry growth. FANDOM SPORTS is hoping to make them fans… of its Android Sports App, now in its second incarnation.

FANDOM SPORTS Media is a sports entertainment company that aggregates, curates and produces unique fan-focused content. The company was established to allow sports fans to play out and give expression to their passion for their sports of choice. Through the social media environment of the platform, they can express their adoration for their teams and players… and bash the other side. The App facilitates uncensored and unfiltered dialogue and rewards fans with virtual currency for their comments.

To touch base with sports fans, FANDOM SPORTS Media has hired an industry leading mobile app marketing and strategy firm to conduct aggressive marketing outreach (http://nnw.fm/KSr0v). The campaign is designed to increase growth and discovery, drive engagement, refine potential revenue opportunities and better position the FANDOM SPORTS App for the successful rollout of its v2 product, scheduled for release in early Q4 2018. Version 2 of the App is an Android adaptation of an earlier iOS version, which the company will now put into hibernation.

The company is employing the tagline, “Pick a Fight”, signaling it intends to go about acquiring users by an appeal to their competitive instincts… an appropriate strategy in the land of free competition.

For more information, visit the company’s website at www.FANDOMSPORTSMedia.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Fandom Sports Media Corp. (FDMSF) Stock Research Links

FDMSF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

A Comprehensive Look at Apple's Competitive Position in Tech

Updated Category News Views 313

Understanding Apple's Competitive Landscape In today's dynamic business environment, a deep-dive analysis of top companies is essential for investors and industry insiders. This examination will focus on Apple (AAPL), alongside its chief rivals in the Technology Hardware, Storage & Peripherals sector. By analyzing crucial financial indicators, market positioning, and...

Continue Reading
Cegedim Shares Insights on Latest Liquidity Contract Performance

Updated Category News Views 135

Overview of Cegedim's Liquidity Contract Statement This article covers the latest updates on Cegedim’s liquidity contract performance, highlighting significant figures and trends that reflect the company's financial health. Cegedim has established a robust liquidity contract with Rothschild Martin Maurel, aimed at promoting transparency and liquidity in its shares. Key...

Continue Reading
Silexion Therapeutics Advances SIL204 for Pancreatic Cancer

Updated Category News Views 136

Silexion Therapeutics Moves Forward with SIL204 Silexion Therapeutics Corp. (NASDAQ: SLXN) is celebrating a significant milestone with the completion of crucial toxicology studies for its innovative RNA silencing therapy, SIL204. This groundbreaking therapy, designed to target mutated KRAS oncogenes, has shown no signs of systemic organ toxicity, reinforcing the...

Continue Reading
Emerson Partners with LifeSight for Enhanced Pension Solutions

Updated Category News Views 178

Emerson Partners with LifeSight for Pension Solutions LifeSight, WTW’s UK defined contribution (DC) master trust, has stepped into a significant role by becoming the full master trust provider for Emerson, the advanced electronics powerhouse. This partnership aims to cover all active, deferred, and drawdown members effectively, ensuring they are well-accommodated in...

Continue Reading
Howard Marks Joins Alliance for Decision Education Board

Updated Category News Views 227

Exciting News from the Alliance for Decision Education The Alliance for Decision Education is thrilled to announce an important addition to its Board of Directors. Howard Marks, a leader in investment management and a well-respected voice in decision-making, has agreed to join the board. As the co-chairman and co-founder of Oaktree Capital Management, Marks brings with...

Continue Reading